U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
183391183391An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neuCompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT00153218
183392183392Serious Medication Errors in Pediatrics: Evaluation of Prevention StrategiesRecruitingNo Results AvailableMedication ErrorsDevice: computerized physician order entryhttps://ClinicalTrials.gov/show/NCT00153205
183393183393Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic PainCompletedNo Results AvailableChronic PainDrug: Marinol (dronabinol)https://ClinicalTrials.gov/show/NCT00153192
183394183394Free Fatty Acids and Vascular Function in Subjects With DiabetesCompletedHas ResultsType 2 Diabetes MellitusDrug: acipimox|Drug: placebohttps://ClinicalTrials.gov/show/NCT00153179
183395183395ARREST PAD (Peripheral Arterial Disease)CompletedHas ResultsArterial Occlusive Disease|Intermittent Claudication|Insulin ResistanceDrug: atorvastatin and pioglitazone|Drug: atorvastatin/placebo|Drug: pioglitazone/placebo|Drug: placebo/placebohttps://ClinicalTrials.gov/show/NCT00153166
183396183396Extended Use of Polyethyleneglycol3350 Laxative in Constipated PatientsCompletedNo Results AvailableConstipationDrug: polyethyleneglycol3350https://ClinicalTrials.gov/show/NCT00153153
183397183397Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic ConstipationCompletedNo Results AvailableConstipationDrug: polyethyleneglycol3350https://ClinicalTrials.gov/show/NCT00153140
183398183398Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating MedicationsCompletedNo Results AvailableConstipationDrug: polyethyleneglycol3350https://ClinicalTrials.gov/show/NCT00153127
183399183399PolyethyleneGlycol3350 Laxative vs Placebo in Constipated ChildrenCompletedNo Results AvailableConstipationDrug: polyethyleneglycol3350https://ClinicalTrials.gov/show/NCT00153114
183400183400Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.CompletedHas ResultsCardiovascular DiseasesDrug: Telmisartan|Drug: Combination of Telmisartan and Ramipril|Drug: Ramiprilhttps://ClinicalTrials.gov/show/NCT00153101
183401183401INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic NephropathyCompletedNo Results AvailableDiabetic NephropathiesDrug: Telmisartan capsule 40 mg|Drug: Placebo|Drug: Telmisartan capsule 80 mghttps://ClinicalTrials.gov/show/NCT00153088
183402183402Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic Obstructive|AsthmaDevice: Berodual Respimat|Device: Berodual HFA-MDIhttps://ClinicalTrials.gov/show/NCT00153075
183403183403PRoFESS - Prevention Regimen For Effectively Avoiding Second StrokesCompletedHas ResultsStrokeDrug: Aggrenox|Drug: Aggrenox|Drug: Clopidogrel placebo|Drug: Clopidogrel placebo|Drug: Micardis|Drug: Micardis|Drug: Aggrenox placebo|Drug: Aggrenox placebo|Drug: Clopidogrel|Drug: Clopidogrel|Drug: Micardis placebo|Drug: Micardis placebohttps://ClinicalTrials.gov/show/NCT00153062
1834041834043 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential HypertensionCompletedNo Results AvailableHypertensionDrug: Telmisartan|Drug: Hydrochlorothiazide|Drug: Telmisartan + Hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00153049
183405183405Rt-PA in the Treatment of Acute Ischemic StrokeCompletedNo Results AvailableCerebrovascular AccidentDrug: rt-PA 0.9 mg/kg verum or placebo Intravenoushttps://ClinicalTrials.gov/show/NCT00153036
1834061834061 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt NephropathyCompletedNo Results AvailableDiabetic Nephropathies|HypertensionDrug: Telmisartan|Drug: Valsartanhttps://ClinicalTrials.gov/show/NCT00153023
183407183407An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's TypeCompletedNo Results AvailableAlzheimer DiseaseDrug: NS 2330 (Tesofensine)https://ClinicalTrials.gov/show/NCT00153010
183408183408Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs SyndromeCompletedNo Results AvailableRestless Legs SyndromeDrug: Pramipexole 0.125 mg tablets|Drug: Pramipexole 0.125 mg tablets Placebohttps://ClinicalTrials.gov/show/NCT00152997
183409183409Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of AsthmaCompletedNo Results AvailablePulmonary Disease, Chronic Obstructive|AsthmaDrug: Tiotropium inhalation capsules|Drug: Placebo inhalation capsuleshttps://ClinicalTrials.gov/show/NCT00152984
183410183410Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee ReplacementCompletedHas ResultsArthroplasty, Replacement, Knee|ThromboembolismDrug: Dabigatran Dose 1 - day 2 to completion|Drug: Dabigatran Dose 1 - day 1|Drug: Dabigatran Dose 2 - day 2 to completion|Drug: Dabigatran Dose 2 - day 1|Drug: Enoxaparinhttps://ClinicalTrials.gov/show/NCT00152971
183411183411A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)CompletedNo Results AvailableRestless Legs SyndromeDrug: Pramipexolehttps://ClinicalTrials.gov/show/NCT00152958
183412183412Determining the Responsiveness of Intestinal Lipoprotein Production to an Elevation of Plasma Free Fatty AcidsCompletedNo Results AvailableInsulin ResistanceDrug: Intravenous Intralipid|Drug: Intravenous leucine, glycerolhttps://ClinicalTrials.gov/show/NCT00152945
183413183413Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With DorzolamideRecruitingNo Results AvailableGlaucomaDrug: Dorzolamide 2% drops|Device: HRF and CLBFhttps://ClinicalTrials.gov/show/NCT00152932
183414183414Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate BrachytherapyCompletedNo Results AvailableProstatic NeoplasmsDrug: Meloxicamhttps://ClinicalTrials.gov/show/NCT00152919
183415183415Stereotactic Radiotherapy (SRT) Liver (COLD 1)Active, not recruitingNo Results AvailableLiver Neoplasms|Neoplasm MetastasesProcedure: Stereotactic radiotherapy (SRT) or highly conformal (CRT)https://ClinicalTrials.gov/show/NCT00152906
183416183416To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic AbnormalitiesCompletedNo Results AvailableHIV InfectionsDrug: chromium nicotinate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00152893
183417183417Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg NegativeRecruitingNo Results AvailableHepatitis Bhttps://ClinicalTrials.gov/show/NCT00152880
183418183418Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic ChemotherapyCompletedNo Results AvailableCancer|Emesis|NauseaDrug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00152867
183419183419Acetaminophen for Cancer PainRecruitingNo Results AvailableCancer|PainDrug: Acetaminophen|Drug: acetaminophen|Drug: placebo, sugar pillhttps://ClinicalTrials.gov/show/NCT00152854
183420183420Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative ColitisTerminatedNo Results AvailableCrohn's Disease|Ulcerative Colitis|Mild or Moderate AnaemiaDrug: Iron supplement 300-600 mg/day|Drug: Vitamin E 800IUhttps://ClinicalTrials.gov/show/NCT00152841

* Görseller ve İçerik tekif hakkına sahip olabilir